Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

NCT00035035

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Huntsville, Alabama, United States
  • Fountain Valley, California, United States
  • Fullerton, California, United States
  • Lancaster, California, United States
View all 114 locations
View Trial Details
Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

NCT00035061

Conditions
Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Boca Raton, Florida, United States
  • Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

NCT00034593

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
Locations
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Helsinki, Finland
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Pikonlinna, Finland
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Turku, Finland
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Bordeaux, France
View Trial Details
Completed

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

NCT00035334

Conditions
Amyloidosis, Arthritis, Arthritis, Rheumatoid, +32 more
Locations
  • Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, Indianapolis, Indiana, United States
  • Boston Medical Center, Renal Division Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Mount Sinai Medical Center New York, United States
View all 26 locations
View Trial Details

Related conditions